An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models Science Nawigacja wpisu FDA approves Stanford Medicine-developed drug that treats rare heart disease – Stanford Medical Center Report What a Gut Fungus Reveals About Symbiosis and Allergy – Weill Cornell Medicine Newsroom
